OTC Markets OTCQX - Delayed Quote USD
Covalon Technologies Ltd. (CVALF)
At close: October 18 at 4:00 PM EDT
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
29,196.2220
26,595.2860
18,146.3900
19,561.3010
13,508.4340
Cost of Revenue
12,714.9560
12,233.4470
10,652.8850
9,864.9700
8,861.0110
Gross Profit
16,481.2660
14,361.8390
7,493.5050
9,696.3310
4,647.4230
Operating Expense
17,857.8260
18,890.3390
16,635.8330
8,857.9880
12,034.6260
Operating Income
-1,376.5600
-4,528.5000
-9,142.3280
838.3430
-7,387.2030
Net Non Operating Interest Income Expense
-56.8520
67.5020
-111.5900
-419.3790
-435.5870
Pretax Income
-823.4040
-4,460.9980
-9,253.9180
418.9640
-7,822.7900
Net Income Common Stockholders
-823.4040
-4,460.9980
-9,663.2130
23,476.9060
-6,952.2240
Diluted NI Available to Com Stockholders
-823.4040
-4,460.9980
-9,663.2130
23,476.9060
-6,952.2240
Basic EPS
-0.04
-0.18
-0.38
0.91
-0.27
Diluted EPS
-0.04
-0.18
-0.38
0.91
-0.27
Basic Average Shares
24,564.5450
24,783.3220
25,429.5080
25,821.2390
25,818.6770
Diluted Average Shares
24,564.5450
24,783.3220
25,429.5080
25,821.2390
25,818.6770
Total Expenses
30,572.7820
31,123.7860
27,288.7180
18,722.9580
20,895.6370
Net Income from Continuing & Discontinued Operation
-823.4040
-4,460.9980
-9,663.2130
23,476.9060
-6,952.2240
Normalized Income
-823.4040
-4,460.9980
-9,253.9180
418.9640
-7,822.7900
Interest Expense
--
--
111.5900
419.3790
435.5870
Net Interest Income
-56.8520
67.5020
-111.5900
-419.3790
-435.5870
EBIT
-1,376.5600
-4,528.5000
-9,142.3280
838.3430
-7,387.2030
EBITDA
-1,376.5600
-4,528.5000
-8,109.5200
1,538.8090
-6,630.5830
Reconciled Cost of Revenue
12,714.9560
12,233.4470
10,652.8850
9,864.9700
8,861.0110
Reconciled Depreciation
--
969.3700
1,032.8080
700.4660
756.6200
Net Income from Continuing Operation Net Minority Interest
-823.4040
-4,460.9980
-9,253.9180
418.9640
-7,822.7900
Normalized EBITDA
-1,376.5600
-4,528.5000
-8,109.5200
1,538.8090
-6,630.5830
Tax Rate for Calcs
--
--
--
0.0003
--
9/30/2020 - 4/18/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
Q9T.F ME Therapeutics Holdings Inc.
3.0200
0.00%
WAVE.V Waverley Pharma Inc.
0.0150
0.00%
GLWLF Glow Lifetech Corp.
0.0370
+47.41%
IOT.V Innovotech Inc.
0.1350
0.00%
TELI.CN Telescope Innovations Corp.
0.4500
+12.50%
GLOW.CN Glow Lifetech Corp.
0.0550
+10.00%
METX.CN METheraHld
5.40
-18.80%
XRTX.V XORTX Therapeutics Inc.
2.6900
+0.75%
BCT.TO BriaCell Therapeutics Corp.
1.1600
0.00%
ZIVO ZIVO Bioscience, Inc.
20.00
+5.26%